Title |
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
|
---|---|
Published in |
Trials, November 2020
|
DOI | 10.1186/s13063-020-04839-5 |
Pubmed ID | |
Authors |
Shaukat Ali, Shobha Luxmi, Fatima Anjum, Sheikh Muhammad Muhaymin, Syed Muneeb Uddin, Ayesha Ali, Mir Rashid Ali, Sohaib Tauheed, Mujtaba Khan, Mohsin Bajwa, Saif Ullah Baig, Elisha Shalim, Iqra Ahmed, Abdul Samad Khan, Saeed Quraishy |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 201 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 201 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 21 | 10% |
Student > Bachelor | 19 | 9% |
Other | 17 | 8% |
Researcher | 15 | 7% |
Student > Ph. D. Student | 12 | 6% |
Other | 39 | 19% |
Unknown | 78 | 39% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 55 | 27% |
Nursing and Health Professions | 25 | 12% |
Social Sciences | 7 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 3% |
Psychology | 4 | 2% |
Other | 16 | 8% |
Unknown | 87 | 43% |